Four lots of 200 rainbow trout embryos were exposed to 200 ml solutions of aqueous 0.5 ppm
aflatoxin B1 (AFB1) for 1 hr, and 4 lots of 200 rainbow trout embryos were
sham-treated for 1 hr. After hatching and swimup, 100 fry from each group were selected for a feeding trial. Two groups of AFB1-treated and 2 groups of
sham-treated fry were fed a control diet, while corresponding groups of AFB1-treated and
sham-treated fry were fed the control diet plus 100 ppm
Aroclor 1254 for 1 year. Samples were taken at 9 and 12 mon to monitor
tumor incidence,
Aroclor 1254 accumulation and histopathology. At the end of 12 mon, the
liver cancer incidences in the combined AFB1-treated, control diet groups and the AFB1-treated,
Aroclor 1254 diet groups were essentially the same. 65.8% and 63.9%, respectively. One trout in the
sham-control,
Aroclor 1254 diet group had a single
liver cancer, but the
sham-control, control diet group had none. The
Aroclor 1254 fed groups had significantly higher liver to
body weight ratios at 12 noon but not at 9 mon. Levels of accumulated
Aroclor 1254 were similar to those reported previously, approximately 75 ppm on a whole fish basis at 12 mon.
Glycogen depletion of hepatocytes and splenic
hyperemia were the only tissue changes induced by
Aroclor 1254.